Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Winter

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
European Journal of Epidemiology|October 3, 2023
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancerKatharina Wichert, Reiner Hoppe, Katja Ickstadt, et al.
American Heart Journal|April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
NPJ Breast Cancer|March 21, 2026
A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrenceChiea Chuen Khor, Whee Sze Ong, Elaine Hsuen Lim, et al.
Clinical Pharmacology and Therapeutics|May 31, 2020
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics ConsortiumShefali Setia Verma, Thomas O Bergmeijer, Li Gong, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 11, 2019
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patientsJoshua P Lewis, Joshua D Backman, Jean-Luc Reny, et al.
NPJ Breast Cancer|February 19, 2025
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancerReiner Hoppe, Stefan Winter, Wing-Yee Lo, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
European Journal of Epidemiology|October 3, 2023
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancerKatharina Wichert, Reiner Hoppe, Katja Ickstadt, et al.
American Heart Journal|April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
NPJ Breast Cancer|March 21, 2026
A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrenceChiea Chuen Khor, Whee Sze Ong, Elaine Hsuen Lim, et al.
Clinical Pharmacology and Therapeutics|May 31, 2020
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics ConsortiumShefali Setia Verma, Thomas O Bergmeijer, Li Gong, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 11, 2019
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patientsJoshua P Lewis, Joshua D Backman, Jean-Luc Reny, et al.
NPJ Breast Cancer|February 19, 2025
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancerReiner Hoppe, Stefan Winter, Wing-Yee Lo, et al.
Pageof 16